The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
- PMID: 15324513
- DOI: 10.1185/030079904X1980
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
Abstract
Objectives: We have developed an Internet-based, interactive computer model to determine the long-term health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus. The model projects outcomes for populations, taking into account baseline cohort characteristics and past history of complications, current and future diabetes management and concomitant medications, screening strategies and changes in physiological parameters over time. The development of complications, life expectancy, quality-adjusted life expectancy and total costs within populations can be calculated.
Methods: The model is based on a series of sub-models that simulate important complications of diabetes (cardiovascular disease, eye disease, hypoglycaemia, nephropathy, neuropathy, foot ulcer, amputation, stroke, ketoacidosis, lactic acidosis and mortality). Each sub-model is a Markov model using Monte Carlo simulation incorporating time, state, time-in state, and diabetes type-dependent probabilities derived from published sources. Analyses can be performed on cohorts with type 1 or type 2 diabetes. Cohorts, defined in terms of age, gender, baseline risk factors and pre-existing complications, can be modified or new cohorts defined by the user. Economic and clinical data in the model can be edited, thus ensuring adaptability by allowing the inclusion of new data as they become available; creation of country- or provider-specific versions of the model; and allowing the investigation of new hypotheses.
Conclusions: The CORE Diabetes Model allows the calculation of long-term outcomes, based on the best data currently available. Diabetes management strategies can be compared in different patient populations in a variety of realistic clinical settings, allowing the identification of efficient diabetes management strategies.
Similar articles
-
Validation of the CORE Diabetes Model against epidemiological and clinical studies.Curr Med Res Opin. 2004 Aug;20 Suppl 1:S27-40. doi: 10.1185/030079904X2006. Curr Med Res Opin. 2004. PMID: 15324514
-
What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model.Curr Med Res Opin. 2004 Aug;20 Suppl 1:S59-66. doi: 10.1185/030079904X2024. Curr Med Res Opin. 2004. PMID: 15324517
-
Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.Curr Med Res Opin. 2004 Aug;20 Suppl 1:S67-73. doi: 10.1185/030079904X2033. Curr Med Res Opin. 2004. PMID: 15324518
-
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127. Pediatrics. 2005. PMID: 15867026 Review.
-
[Health economics analysis of diabetes is necessary. It facilitates decision-making and international comparison].Lakartidningen. 1999 Sep 15;96(37):3915-6, 3919. Lakartidningen. 1999. PMID: 10522101 Review. Swedish.
Cited by
-
Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy.Clinicoecon Outcomes Res. 2019 Oct 7;11:605-614. doi: 10.2147/CEOR.S218746. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 31632108 Free PMC article.
-
Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden.Eur Endocrinol. 2018 Sep;14(2):73-79. doi: 10.17925/EE.2018.14.2.73. Epub 2018 Sep 10. Eur Endocrinol. 2018. PMID: 30349598 Free PMC article. Review.
-
Complication reducing effect of the information technology-based diabetes management system on subjects with type 2 diabetes.J Diabetes Sci Technol. 2008 Jan;2(1):76-81. doi: 10.1177/193229680800200111. J Diabetes Sci Technol. 2008. PMID: 19885180 Free PMC article.
-
A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment.Pharmacoeconomics. 2010;28(4):255-77. doi: 10.2165/11531590-000000000-00000. Pharmacoeconomics. 2010. PMID: 20222752 Review.
-
Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.Ont Health Technol Assess Ser. 2019 Dec 12;19(8):1-108. eCollection 2019. Ont Health Technol Assess Ser. 2019. PMID: 31942227 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous